Supernus Share Price

Supernus Share Price

NASDAQ: SUPN | Small Cap | Healthcare
$28.98
-$0.09 (-0.33%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Supernus Stock Performance

Open
$29.00
Prev. Close
$29.07
Circuit Range
N/A
Day Range
$28.71 - $29.75
Year Range
$25.93 - $59.45
Volume
1,75,882
Average Traded
$28.99

Supernus Share Price Today

As of 19 November 2026, Supernus, Inc.'s share price is $28.98. The stock opened at $29.00, compared to its previous close of $29.07. During today's trading session, Supernus, Inc.'s share price traded between $28.71 and $29.75, with an average price of $29.23. Over the past 52 weeks, the stock has recorded a high of $59.45 and a low of $25.93. In terms of performance, Supernus, Inc.'s share price has declined by 37.20% over the last six months and is down 36.58% on a year-on-year basis.

Supernus Share Price Chart

Line chart of the Supernus price trend over the selected period. The price fell overall, ranging from 28.71 to 29.75, ending at 28.98.
$28.71$29.75
L
Show Current Price
H

Supernus Stock Fundamentals & Key Indicators

Market Cap
$1.64B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.75
Revenue (TTM)
$718.95B
Return On Equity (TTM)
-4.13%
Profit Margin
-5.36%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
608.76%

Supernus Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$211.57$207.71$219.06$226.77
Net Profit-$4.11-$2.29-$58.37$20.91
Net Profit Margin-1.94%-1.10%-26.65%9.22%
Income ChangeN/A44.28%-2448.91%135.82%

Supernus Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$667.24$607.52$661.82$718.95
Net Profit$60.71$1.32$73.87-$38.55
Net Profit Margin9.10%0.22%11.16%-5.36%
Income ChangeN/A-97.83%5496.21%-152.19%

Supernus Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets808.47682.0784.56968.36
Current Assets644.18686.07493.11734.15
Total Assets1452.651368.071277.671702.51
Non Current Liabilities52.7639.9465.96128.35
Current Liabilities338.17292.4290.2687.96
Total Liabilities390.93332.34356.16816.3
Shareholders' Equity1061.711035.73921.52886.2

Supernus Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating47.33171.95111.09116.83
Investing4.11-189.87268.73-216.66
Financing9.1312.19-397.88-10.48

Corporate Actions

Dividend
Ex-date: 03 Nov 2026

About Supernus

Supernus Inc is a diversified biopharmaceutical company focused on developing and commercializing treatments for patients living with central nervous system (CNS) diseases. The company's commercial portfolio includes approved treatments designed to support individuals navigating opioid use disorder (OUD), attention-deficit hyperactivity disorder (ADHD), dyskinesia in Parkinson's disease (PD) for those receiving levodopa-based therapy, hypomobility in PD, postpartum depression (PPD), epilepsy, migraine, cervical dystonia, and chronic sialorrhea.

Supernus Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$28.60
$28.97
-30.86%
Oct 2026
$43.23
$41.90
-2.77%
Sep 2026
$44.52
$43.09
-2.48%
Aug 2026
$50.45
$44.19
-0.99%
Jul 2026
$46.95
$44.63
-4.08%
Jun 2026
$46.02
$46.53
+0.85%
May 2026
$47.81
$46.14
-3.87%
Apr 2026
$51.37
$48.00
-7.12%
Mar 2026
$54.52
$51.68
-5.64%
Feb 2026
$48.63
$54.77
+13.70%
Jan 2026
$49.27
$48.17
-3.03%
Dec 2025
$45.45
$49.67
+8.72%

Supernus Share Price FAQs